We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Enhanced Recovery After Laparoscopic Sleeve Gastrectomy - a Randomised Controlled Trial

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01303809
First Posted: February 25, 2011
Last Update Posted: May 25, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Auckland Medical Research Foundation
Information provided by (Responsible Party):
SACS, University of Auckland, New Zealand
  Purpose
The investigators wish to standardise and optimise perioperative care for consecutive patients undergoing laparoscopic sleeve gastrectomy for weight loss. The investigators will compare patients under a standardised perioperative care program to patients who undergo routine perioperative in our hospital and determine whether patients who had optimised perioperative care went home earlier and had fewer complications.

Condition Intervention
Morbid Obesity Other: Enhanced Recovery After Surgey for Sleeve Gastrectomy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Enhanced Recovery After Laparoscopic Sleeve Gastrectomy - a Randomised Controlled Trial

Further study details as provided by SACS, University of Auckland, New Zealand:

Primary Outcome Measures:
  • Length of Hospital Stay [ Time Frame: day of discharge ]
    The trial intends to investigate whether median length of hospital stay for patients under a standardised optimised perioperative care program is less than patients who have routine perioperative care that undergo the same operation.


Secondary Outcome Measures:
  • Complications [ Time Frame: 30 days ]
    The study will investigate complication rate for each group identifying incidence, type and severity of complication according to the Clavien Dindo Classification system

  • Readmission rates [ Time Frame: 30 days ]
    The number of patients per group who represent to hospital for any reason during a 30 day period after the day of surgery

  • Postoperative fatigue [ Time Frame: Baseline and postoperative days 1, 7 and 14 ]
    A measure functional recovery after surgery as measured by the validated surgical recovery scale.

  • Compliance to the ERAS protocol [ Time Frame: through to day 1 postoperatively ]
    Prospectively recording whether components of the ERAS programme are being carried out as per protocol.


Enrollment: 106
Study Start Date: May 2011
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: ERAS
The perioperative management of the patients in this arm will be according to a fast-track protocol designed by the investigators. The preoperative component of this program is the same as routine practice. Intraoperative and postoperative components which are different to routine practice are as described in the intervention section. This protocol is based on current literature regarding Enhanced Recovery After Surgery (ERAS).
Other: Enhanced Recovery After Surgey for Sleeve Gastrectomy

Intraoperative:

  1. Pre-op carbohydrate loading
  2. No pre-op GIK while NBM
  3. Pre-medication
  4. Dexamethasone 4mg as antiemetic, IV Paracetamol (first dose) Parecoxib 40mg
  5. Ondansetron regularly for first 48 hours and Cyclizine, Droperidol or Scopaderm as rescue antiemetics
  6. Fluid restriction
  7. Standardised method of anaesthesia
  8. Give 40ml 0.5% bupivacaine with adrenaline administered prior to placement of laparoscopic port sites
  9. 10ml 0.75% ropivacaine diluted to 50ml with 0.9% normal saline solution administered to surgical site prior to procedure

Postoperative:

  1. Rescue PCA for up to 12 hours. Oxynorm 5mg for rescue pain. Oxycontin 20mg bd/prn postoperatively
  2. Maintenance IV fluids (60ml/hr plasmalyte to be stopped 0800 day 1 post op). Clear oral fluids 2 hours post op. Bariatric free oral fluids morning of day 1
  3. Post operative oxygenation
  4. Incentive spirometry
  5. Drains (e.g. IDC) removed in recovery
  6. Full mobilisation 4-8 hours post op)
  7. Early Follow up
Other Names:
  • ERAS for sleeve gastrectomy
  • Fast-Track for sleeve gastrectomy
No Intervention: non ERAS
The perioperative management of patients in this arm will be according to routine practice currently implemented at our institution.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients undergoing laparascopic sleeve gastrectomy for weight loss by surgeons who have agreed to participate in the study
  • Surgery occurs at Manukau Surgery Centre

Exclusion Criteria:

  • Surgery not occuring in Manukau Superclinic
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01303809


Locations
New Zealand
Manukau Surgery Centre
Auckland, New Zealand, 2025
Sponsors and Collaborators
University of Auckland, New Zealand
Auckland Medical Research Foundation
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: SACS, Professor Andrew G. Hill, University of Auckland, New Zealand
ClinicalTrials.gov Identifier: NCT01303809     History of Changes
Other Study ID Numbers: BariatricFastTrack
First Submitted: February 24, 2011
First Posted: February 25, 2011
Last Update Posted: May 25, 2012
Last Verified: May 2012

Keywords provided by SACS, University of Auckland, New Zealand:
Perioperative care
Fast-track
Enhanced Recovery After Surgery
ERAS
Obesity
Bariatric surgery
Laparoscopic Sleeve Gastrectomy

Additional relevant MeSH terms:
Obesity, Morbid
Obesity
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms